OOIR: Observatory of International Research

Papers

(The median citation count of Emerging Infectious Diseases is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients	1262
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2	1136
Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020	762
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020	657
US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2	479
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases	475
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States	467
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Social Distancing Measures	430
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020	427
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19	414
Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020	392
Coronavirus Disease Outbreak in Call Center, South Korea	385
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic	382
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020	378
Public Mental Health Crisis during COVID-19 Pandemic, China	373
Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China	362
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020	362
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease	315
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States	303
Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong	295
Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China	290
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India	290
Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018	286
Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018	281
Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols	273

Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China	243
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions	243
Rhabdomyolysis as Potential Late Complication Associated with COVID-19	243
Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality	231
Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China	227
Decreased Influenza Incidence under COVID-19 Control Measures, Singapore	224
SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark	219
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2	213
Identifying and Interrupting Superspreading Events—Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2	210
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020	208
Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea	197
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease	190
Imported Monkeypox, Singapore	188
Clusters of Coronavirus Disease in Communities, Japan, January–April 2020	180
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020	167
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil	165
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus	165
Prolonged Infectivity of SARS-CoV-2 in Fomites	160
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures	157
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States	157
Transmission of SARS-CoV 2 During Long-Haul Flight	154
Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium	154
Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea	153
Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand	149
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France	146
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations	145
Estimating Risk for Death from Coronavirus Disease, China, January–February 2020	145
Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020	144
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China	143
Imported Monkeypox from International Traveler, Maryland, USA, 2021	142
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan	141
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids	140
SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China	138
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021	138
SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020	137
Experimental Infection of Cattle with SARS-CoV-2	136
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020	134
Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection	133
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum	132
Aspergillosis Complicating Severe Coronavirus Disease	128
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan	126
Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2	116
Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan	114
Policy Decisions and Use of Information Technology to Fight Coronavirus Disease, Taiwan	114
Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan	113
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020	113
Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2	111
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient	109
Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents	108
Viral Interference between Respiratory Viruses	102

Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan	101
Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2	99
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection	99
Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021	98
Comparison of Lyme Disease in the United States and Europe	98
Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020	97
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection	95
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces	95
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity	93
Epidemiology of Coronavirus Disease in Gansu Province, China, 2020	91
Severe Fever with Thrombocytopenia Syndrome, Japan, 2013–2017	90
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020	90
Geographic Expansion of Sporotrichosis, Brazil	89
Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States	88
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 RNA on Surfaces in Quarantine Rooms	87
Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight	87
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG	86
Global Trends in Norovirus Genotype Distribution among Children with Acute Gastroenteritis	84
Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2	83
Susceptibility of Domestic Swine to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2	81
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1	80
Intercontinental Movement of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4 Virus to the United States, 2021	80
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—International Travel-Related Measures	80
Impact of Social Distancing Measures on Coronavirus Disease Healthcare Demand, Central Texas, USA	80
Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022	77
Zoonotic Vectorborne Pathogens and Ectoparasites of Dogs and Cats in Eastern and Southeast Asia	76
SARS-CoV-2 Exposure in Escaped Mink, Utah, USA	76
Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands	75
Addressing COVID-19 Misinformation on Social Media Preemptively and Responsively	72
Anopheles stephensi Mosquitoes as Vectors of Plasmodiumvivax and falciparum, Horn of Africa, 2019	71
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar	71
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020	71
Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples	70
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021	70
Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination	69
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease	69
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa)	66
Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018	66
Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry	66
SARS-CoV-2 Delta Variant among Asiatic Lions, India	64
SARS-CoV-2 Wastewater Surveillance for Public Health Action	64
Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units	63
Postvaccination COVID-19 among Healthcare Workers, Israel	63
Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy	62
Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity	62
Lessons Learned from a Decade of Investigations of Shiga Toxin–Producing Escherichia coli Outbreaks Linked to Leafy Greens, United States and Canada	61
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020	61
Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing	60
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany	60
COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020	60
Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019	60
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020	60
Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China	59
In-Flight Transmission of SARS-CoV-2	59
Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin	59
Genotypic Heterogeneity of Orientia tsutsugamushi in Scrub Typhus Patients and Thrombocytopenia Syndrome Co-infection, Myanmar	59
Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021	58
Doubling Time of the COVID-19 Epidemic by Province, China	58
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19	58
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva	58
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China	58
Molecular Description of a Novel Orientia Species Causing Scrub Typhus in Chile	58
Serologic Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and Related Viruses in Pakistan	57
Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing	56
Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain	56
Natural SARS-CoV-2 Infection in Kept Ferrets, Spain	56
Epidemiology of Early Monkeypox Virus Transmission in Sexual Networks of Gay and Bisexual Men, England, 2022	56
Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei	55
SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May–June 2020	55
Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021	55
Peridomestic Mammal Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection	55
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients	54
Coronavirus Disease Exposure and Spread from Nightclubs, South Korea	54
Public Mental Health Crisis during COVID-19 Pandemic, China	54
Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand	53
Characteristics of SARS-CoV-2 Transmission among Meat Processing Workers in Nebraska, USA, and Effectiveness of Risk Mitigation Measures	53
Natural Human Infections with Plasmodium cynomolgi, P. inui, and 4 other Simian Malaria Parasites, Malaysia	53
Environmental Persistence of Monkeypox Virus on Surfaces in Household of Person with Travel-Associated Infection, Dallas, Texas, USA, 2021	52
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany	52
Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020	52

Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea	51
Norovirus Outbreak Surveillance, China, 2016–2018	51
Direct Transmission of Severe Fever with Thrombocytopenia Syndrome Virus from Domestic Cat to Veterinary Personnel	51
Highly Pathogenic Avian Influenza A(H5N1) Virus in Wild Red Foxes, the Netherlands, 2021	51
High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020	51
Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China	51
Effect of COVID-19 on Tuberculosis Notification, South Korea	50
Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection	50
Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda	50
Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands	49
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020	49
Parotitis-Like Symptoms Associated with COVID-19, France, March–April 2020	49
Large Outbreak of Coronavirus Disease among Wedding Attendees, Jordan	49
Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in New England Seals, United States	48
Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea	48
Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France	48
Reflections on 40 Years of AIDS	48
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees	48
Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi	48
Panton-Valentine Leukocidin–Secreting Staphylococcus aureus Pneumonia Complicating COVID-19	47
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe	47
Encephalitis and Death in Wild Mammals at a Rehabilitation Center after Infection with Highly Pathogenic Avian Influenza A(H5N8) Virus, United Kingdom	46
Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination	45
Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England	45
Naturally Acquired Human Plasmodium cynomolgi and P. knowlesi Infections, Malaysian Borneo	45
Early Estimates of Monkeypox Incubation Period, Generation Time, and Reproduction Number, Italy, May–June 2022	44
Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19	44
Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses	44
Predictors of Nonseroconversion after SARS-CoV-2 Infection	44
Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June–October 2020	44
Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013–2018	44
Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy	44
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022	43
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis	43
Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020	43
Stemming the Rising Tide of Human-Biting Ticks and Tickborne Diseases, United States	43
Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia	43
Food Safety and InvasiveCronobacterInfections during Early Infancy, 1961–2018	42
Epidemiologic Changes of Scrub Typhus in China, 1952–2016	42
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications	42
Incidence of Acute Rheumatic Fever and Rheumatic Heart Disease among Ethnic Groups, New Zealand, 2000–2018	42
Guillain-Barré Syndrome Associated with COVID-19 Vaccination	42
Atypical Manifestations of Cat-Scratch Disease, United States, 2005–2014	42
Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020	42
Effects of COVID-19 Prevention Measures on Other Common Infections, Taiwan	41
SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA	41
Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam	40
Increased Incidence of Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004–2016	40
Large Nationwide Outbreak of Invasive Listeriosis Associated with Blood Sausage, Germany, 2018–2019	40
COVID-19–Associated Mold Infection in Critically Ill Patients, Chile	40
Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020	40
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy	40
COVID-19 in 2 Persons with Mild Upper Respiratory Tract Symptoms on a Cruise Ship, Japan	39
Psychobehavioral Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong	38
Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015–2017	38
Emergence of New Non–Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Isolates, France	38
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection	38
Cross-Sectional Serosurvey of Companion Animals Housed with SARS-CoV-2–Infected Owners, Italy	37
Acquisition of Plasmid with Carbapenem-Resistance Gene bla_KPC2 in Hypervirulent Klebsiella pneumoniae, Singapore	37
Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States	37
Active Case Finding of Current Bornavirus Infections in Human Encephalitis Cases of Unknown Etiology, Germany, 2018–2020	37
Outbreaks of Highly Pathogenic Avian Influenza (H5N6) Virus Subclade 2.3.4.4h in Swans, Xinjiang, Western China, 2020	37
Potential Role of Social Distancing in Mitigating Spread of Coronavirus Disease, South Korea	37
Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China	37
Role of Anopheles stephensi Mosquitoes in Malaria Outbreak, Djibouti, 2019	36
Industry Sectors Highly Affected by Worksite Outbreaks of Coronavirus Disease, Los Angeles County, California, USA, March 19–September 30, 2020	36
Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea	36
Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada	36
Developing Endemicity of Schistosomiasis, Corsica, France	36
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201	35
Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices	35
Severe Dengue Epidemic, Sri Lanka, 2017	35
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020	35
Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021	34
Invasive Malaria Vector Anopheles stephensi Mosquitoes in Sudan, 2016–2018	34
Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2	34
Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020	34
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain	34
Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020	34
Differential Yellow Fever Susceptibility in New World Nonhuman Primates, Comparison with Humans, and Implications for Surveillance	34
Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic	33
CrAssphage as a Novel Tool to Detect Human Fecal Contamination on Environmental Surfaces and Hands	33
Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China	33
Listeriosis Caused by Persistence of Listeria monocytogenes Serotype 4b Sequence Type 6 in Cheese Production Environment	33
Epidemiology of COVID-19 Outbreak on Cruise Ship Quarantined at Yokohama, Japan, February 2020	33
Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020	33
Role of Oral Rabies Vaccines in the Elimination of Dog-Mediated Human Rabies Deaths	32
Melioidosis in a Resident of Texas with No Recent Travel History, United States	32
Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States	32
Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May–July 2020	32
Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe	32
Monkeypox Virus Transmission to Healthcare Worker through Needlestick Injury, Brazil	32
Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020	32
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020	32
Clinical Outcomes of Patients Treated for Candida auris Infections in a Multisite Health System, Illinois, USA	32